Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intelligent Bio Solutions (INBS) Cash from Investing Activities (2022 - 2025)

Intelligent Bio Solutions has reported Cash from Investing Activities over the past 3 years, most recently at $2551.0 for Q1 2024.

  • For Q1 2024, Cash from Investing Activities fell 98.53% year-over-year to $2551.0; the TTM value through Mar 2024 reached -$216700.0, up 82.17%, while the annual FY2023 figure was -$694142.0, 21.14% up from the prior year.
  • Cash from Investing Activities for Q1 2024 was $2551.0 at Intelligent Bio Solutions, up from -$181750.0 in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $173803.0 in Q1 2023 and troughed at -$703013.0 in Q2 2022.
  • A 3-year average of -$232434.0 and a median of -$196527.0 in 2022 define the central range for Cash from Investing Activities.
  • Biggest five-year swings in Cash from Investing Activities: surged 74.15% in 2023 and later plummeted 98.53% in 2024.
  • Year by year, Cash from Investing Activities stood at -$211304.0 in 2022, then grew by 13.99% to -$181750.0 in 2023, then soared by 101.4% to $2551.0 in 2024.
  • Business Quant data shows Cash from Investing Activities for INBS at $2551.0 in Q1 2024, -$181750.0 in Q2 2023, and $173803.0 in Q1 2023.